Here is why this happens and how to take full advantage of it
The first GLP- 1 medication (Exenatide) was approved in 2005 by the U.S
Immune-related adverse events, which were not observed previously, appeared in 4 patients with positive and 2 with negative treatment-emergent antibodies
"These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss," Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview included in the Cure report, "maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well." Troubling Pattern in Patient Adherence to GLP-1 Drug Therapy Despite their effectiveness, adhering to the injectable drugs have proven challenging
A provider will review your info and prescribe the right GLP-1 treatment for you, if eligible
Individual results vary based on baseline body composition, adherence, and lifestyle factors